Lionsgate Studios
LION
11.31
-0.04
-0.35%
Lionsgate Studios
US · LION
#2410 by market cap
Listed 1970
11.31
-0.04
-0.35%
Live - 5344 symbols - heartbeat 109s ago
· 2026-10-08 07:58
Pre-market
11.31
0.00%
After-hours
11.30
-0.09%
- Market cap
- 3.37B
- P/E (TTM)i
- -28.28
- P/Bi
- -2.80
- EPSi
- -0.70
- Div yieldi
- 0.00%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on LION?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.43, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 6 years
Latest year +1.82% YoY
Margins
- Gross margin
- 39.80%
- Operating margin
- 5.62%
- Net margin
- -7.56%
Key ratios & quality
- Enterprise valuei
- 6.91B
- Altman Z-Scorei
- -0.43
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | 1.91B | 2.72B | 3.08B | 2.45B | 2.58B | 2.63B |
| Gross profit | 692.90M | 794.20M | 875.90M | 981.20M | 844.40M | 1.05B |
| Selling & admin expenses | 558.70M | 657.90M | 691.20M | 850.00M | 756.40M | 881.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 117.00M | 118.20M | 166.80M | 115.60M | 70.20M | 148.00M |
| Pretax profit | -17.90M | 11.20M | 5.40M | -239.50M | -277.30M | -159.30M |
| Tax | 17.30M | 17.30M | 14.30M | 21.70M | 17.20M | 16.20M |
| Net profit | -35.20M | -6.10M | -8.90M | -1.12B | -373.60M | -192.00M |
| Basic EPS | 0 | 0 | 0 | -4 | -1 | -1 |
| Diluted EPS | -0.07 | 0.04 | 0.00 | -3.90 | -1.43 | -0.70 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 865.60M | 525.90M | 475.10M | 724.30M | 906.50M | 776.60M |
| Gross profit | 284.40M | 186.90M | 174.80M | 297.00M | 388.70M | 279.60M |
| Selling & admin expenses | 178.90M | 188.30M | 190.70M | 247.30M | 255.60M | 246.70M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 100.90M | -5.80M | -20.30M | 45.30M | 128.70M | 28.50M |
| Pretax profit | 3.10M | -85.30M | -109.80M | -37.70M | 73.40M | -21.50M |
| Tax | 3.40M | 6.40M | 1.80M | 6.70M | 1.30M | 7.80M |
| Net profit | -114.10M | -106.60M | -113.20M | -44.40M | 72.10M | -29.30M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.10 | -0.40 | -0.39 | -0.16 | 0.23 | -0.10 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 1.01B | 1.15B | 1.37B | 1.24B | 1.49B |
| Cash & ST investments | -- | 256.90M | 210.90M | 277.00M | 212.50M | 341.50M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 4.33B | 4.41B | 5.10B | 6.82B | 5.33B |
| Total current liabilities | -- | 1.89B | 2.11B | 3.64B | 3.47B | 3.05B |
| Short-term debt | -- | 882.30M | 965.10M | 2.25B | 1.75B | 1.46B |
| Long-term debt | -- | 1.88B | 2.22B | 1.47B | 2.20B | 2.43B |
| Total liabilities | -- | 4,264,000,000.00 | 4,848,000,000.00 | 6,129,900,000.00 | 7,081,100,000.00 | 6,376,500,000.00 |
| Total equity | -- | 61.70M | -435.30M | -1.03B | -259.00M | -1.05B |
| Retained earnings | -- | -- | -- | -1.25B | -3.53B | -3.73B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.24B | 1.41B | 1.30B | 1.32B | 1.49B | 1.46B |
| Cash & ST investments | 212.50M | 186.10M | 202.40M | 182.40M | 341.50M | 425.80M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 6.82B | 5.16B | 5.16B | 5.24B | 5.33B | 5.33B |
| Total current liabilities | 3.47B | 3.13B | 2.82B | 2.87B | 3.05B | 3.32B |
| Short-term debt | 1.75B | 1.66B | 1.33B | 1.37B | 1.46B | 1.78B |
| Long-term debt | 2.20B | 2.07B | 2.56B | 2.60B | 2.43B | 2.15B |
| Total liabilities | 7,081,100,000.00 | 6,164,000,000.00 | 6,275,900,000.00 | 6,375,700,000.00 | 6,376,500,000.00 | 6,391,100,000.00 |
| Total equity | -259.00M | -1.00B | -1.12B | -1.13B | -1.05B | -1.06B |
| Retained earnings | -3.53B | -3.64B | -3.76B | -3.80B | -3.73B | -3.76B |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Operating cash flow | -232.40M | -435.00M | 346.10M | 396.80M | -166.00M | 24.80M |
| Depreciation & amortization | 830.50M | 1.60B | 1.67B | 945.40M | 1.19B | 1.04B |
| Free cash flow | -242.60M | -441.10M | 339.60M | 386.90M | -179.50M | 11.40M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 361.30M | 270.30M | 251.40M | 371.40M | 291.60M | 419.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 193.70M | -31.00M | -104.00M | -108.90M | 268.70M | 54.10M |
| Depreciation & amortization | 405.20M | 228.80M | 223.80M | 240.30M | 347.20M | 269.30M |
| Free cash flow | 190.10M | -34.50M | -107.20M | -111.90M | 265.00M | 51.20M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 291.60M | 257.60M | 286.90M | 248.00M | 419.80M | 499.40M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -- | 0.26 | -0.01 | -23.43 | -2.42 | -3.81 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.80 | 2.93 | 4.74 | 0.29 | 3.33 | 3.81 |
| FCF / sales %i | -- | -- | 11.01 | 15.79 | -- | 0.43 |
| Current ratioi | -- | 0.54 | 0.55 | 0.38 | 0.36 | 0.49 |
| Quick ratioi | -- | 0.50 | 0.52 | 0.35 | 0.30 | 0.45 |
| Debt / assetsi | -- | 48.66 | 72.15 | 72.92 | 57.99 | 73.02 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 0.84 | 1.16 | 1.04 | 0.03 | 0.49 | 0.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 8.60 | -1.64 | -5.15 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -67.74 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -2.42 | -3.31 | -2.36 | -2.77 | -3.81 | -2.27 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.33 | 3.57 | 5.12 | 4.99 | 3.81 | 5.29 |
| FCF / sales %i | -- | 0.25 | -- | -- | 0.43 | 3.37 |
| Current ratioi | 0.36 | 0.45 | 0.46 | 0.46 | 0.49 | 0.44 |
| Quick ratioi | 0.30 | 0.41 | 0.42 | 0.42 | 0.45 | 0.41 |
| Debt / assetsi | 57.99 | 72.19 | 75.39 | 75.80 | 73.02 | 73.86 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 0.49 | 0.51 | 0.79 | 0.71 | 0.39 | 0.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Motion Picture is the largest reported line at 75.62% of revenue, across 2 reported segments.
- The next-largest line, Television Production, is a distant second at 24.38% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Motion Picture75.62%
Television Production24.38%
Quote time 2026-10-08 07:58:18 · For reference only, not investment advice and not tailored to your situation.